Skyline Medical Reports First Quarter 2016 Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Skyline Medical Reports First Quarter 2016 Financial Results

MINNEAPOLIS, May 23, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ: SKLN ) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three months ended March 31, 2016.

Highlights of the first quarter of 2016 and recent weeks include:

  • Issuance of a case study by Tucson Medical Center’s radiology department showing the STREAMWAY System reduced waste fluid disposal costs per procedure by 77.6% and generated a positive ROI within the first nine months of use
  • Engaged an independent distributor to expand customer reach in the Southeastern U.S.
  • Presented at the Association for Radiologic & Imaging Nursing (ARIN) 35 th Annual Spring Convention
  • Exhibited at the Association of Veterans Affairs Surgeons (AVAS) conference
  • Completed the installation of upgraded STREAMWAY Systems to the entire installed base
  • Completed a registered exchange offer and issued new Series B Warrants in exchange for Series A Warrants
  • Reported revenue of $96,905 for the first quarter of 2016, compared with $151,274 for the first quarter of 2015
  • Reported net loss available to common shareholders for the first quarter of 2016 of $2,176,369, or $0.12 per share, compared with a net loss available to common shareholders for the first quarter of 2015 of $225,795, or $0.07 per share
  • Customers installed 94 STREAMWAY systems in 50 facilities across 19 states

Management Commentary

“We are keenly focused on sales and marketing and took a number of positive steps during the quarter and recent weeks to broaden awareness of our STREAMWAY System,” said Dr. Carl Schwartz, interim chief executive officer of Skyline Medical.  “We had success in branching out to the radiology market including presenting at the ARIN’s 35 th Annual Spring Convention, where the feedback was excellent.  Our focus on radiology is supported by a Tucson Medical Center case study showing STREAMWAY allowed their radiology department to lower waste fluid disposal costs per procedure by 77.6% or $24.00, a significant improvement from the $107.10 they previously were spending on each procedure using evacuated bottles. Ongoing annual savings from their one STREAMWAY System are expected to be $22,140.   

“We also exhibited at the AVAS conference and intend to continue participating in industry events to market the STREAMWAY to surgeons, nurses and other medical professionals. During the first quarter we signed an agreement with an independent distributor with a track record of selling medical devices to major hospital chains across the Southeast U.S. Our priorities going forward include hiring a new vice president of sales who can drive our sales and marketing efforts and oversee direct and distributed sales. We expect to have this position filled in the second quarter of this year.”

“During the first quarter we completed replacing older STREAMWAY Systems with the latest generation product. Although this upgrade was necessary to ensure our customers have state-of-the art systems, it temporarily pressured our margins. Looking to the remainder of 2016, we expect gross margin to improve as higher sales allow us to achieve economies of scale in the production of equipment components, disposable products and our cleaning solution,” he continued.

“During the first few months of 2016 we undertook a significant effort to improve our capital structure through completing the warrant exchange offer. With the exchange offer now complete we anticipate a reduction in legal and professional fees, which will allow us to redirect funds toward growing sales. Our work so far this year has largely been to secure the future of our business, and we are now in a much better position to focus on sales and marketing of the STREAMWAY System. With no debt, recurring revenues and an exceptional product, the Company’s future prospects look promising,” concluded Dr. Schwartz.

First Quarter Financial Results

Revenue for the first quarter of 2016 was $96,905, compared with $151,274 for the first quarter of 2015.  Revenue was derived from sales of disposable products during the first quarter of 2016, compared with sales of STREAMWAY Systems and disposable products in the first quarter of 2015.

Gross profit for the first quarter of 2016 was $11,022, or 11% of revenue, compared with $55,306, or 37% of revenue, for the same period in 2015. The gross margin declined as the Company replaced older STREAMWAY units with new generation units at no charge to its customers during the 2016 quarter.

Net loss available to common shareholders for the first quarter of 2016 was $2,176,369, or $0.12 per share, compared with a net loss available to common shareholders for the first quarter of 2015 of $225,795, or $0.07 per share.

The Company had cash, cash equivalents and marketable securities of $3,338,642 as of March 31, 2016, compared with $4,856,232 as of December 31, 2015.  The Company used $1,587,882 in cash to fund operations during the first quarter of 2016.

About the STREAMWAY System

Skyline's revolutionary, FDA-cleared STREAMWAY system is the first true direct-to-drain fluid disposal system designed specifically for medical applications, such as radiology, endoscopy, urology and cystoscopy procedures. It connects directly to a facility's plumbing system to automate the collection, measurement and disposal of waste fluids.  As of March 31, 2016, Skyline Medical customers have installed 94 STREAMWAY systems in 50 facilities across 19 states.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Association (OSHA) and other regulatory agency safety guidelines. It also provides unlimited capacity for increased efficiency in the operating room, which leads to greater profitability. Furthermore, the STREAMWAY eliminates canisters to reduce overhead costs and provides greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the U.S.  For a demonstration please visit www.skylinemedical.com or call 855-785-8855.

About Skyline Medical Skyline Medical produces a fully automated, patented, FDA-cleared waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers; 2) improve compliance with Occupational Safety and Health Association (OSHA) and other regulatory agency safety guidelines; 3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability; and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S.  For additional information, please visit www.skylinemedical.com .

Forward-looking Statements Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; the features of the Company’s Series A Warrants that include a cashless exercise feature that has the potential to be highly dilutive, and the existence of which may depress the price of our common stock regardless of the Company’s business performance; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov .  This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position. See the Company's most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov .

  (Tables to follow)

 
SKYLINE MEDICAL INC.
CONDENSED BALANCE SHEETS
(Unaudited)
       
  March 31, 2016   December 31, 2015
.
Current Assets:      
Cash and cash equivalents $ 2,535,792     $ 4,856,232  
Marketable Securities   802,850      
Accounts Receivable   52,778       38,283  
Inventories   256,531       231,740  
Prepaid Expense and other assets   170,889       271,579  
Total Current Assets   3,818,840       5,397,834  
       
Fixed Assets, net   137,633       139,598  
Intangibles, net   94,578       94,987  
       
Total Assets $ 4,051,051     $ 5,632,419  
       
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:      
Accounts Payable $ 791,684     $ 650,413  
Accrued Expenses   722,988       864,295  
Deferred Revenue   5,000       5,000  
Total Current Liabilities   1,519,672       1,519,708  
               
Total Liabilities   1,519,672       1,519,708  
Commitments and Contingencies   -       -  
Stockholders Equity:      
Series B Convertible Preferred Stock, $.01 par value, 10,000,000 authorized, 690,527 and 1,895,010 outstanding   6,905       18,950  
Common Stock, $.01 par value, 100,000,000 authorized, 53,259,529 and 5,206,428 outstanding   532,594       52,063  
Additional paid-in capital   44,657,835       44,534,135  
Accumulated deficit   (42,668,806 )     (40,492,437 )
Accumulated Other Comprehensive income   2,850       -  
Total Stockholders' Equity   2,531,379       4,112,711  
       
Total Liabilities and Stockholders' Equity $ 4,051,051     $ 5,632,419  
               
SKYLINE MEDICAL INC.
CONDENSED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME
(Unaudited)
   
  Three Months Ended March 31,
    2016       2015  
Revenue $ 96,905     $ 151,274  
       
Cost of goods sold   85,883       95,968  
       
Gross margin   11,022       55,306  
       
General and administrative expense   1,688,577       (127,795 )
       
Operations expense   390,366       21,317  
       
Sales and marketing expense   108,448       233,957  
       
Interest expense   -       153,622  
       
Total Expense   2,187,391       281,101  
       
Net loss available to common shareholders   (2,176,369 )     (225,795 )
       
Other comprehensive gain      
Unrealized gain from marketable securities   2,850       -  
       
Comprehensive (loss) $ (2,173,519 )   $ (225,795 )
       
Loss per common share - basic and diluted $ (0.12 )   $ (0.07 )
       
Weighted average shares used in computation - basic and diluted   18,096,204       3,100,244  
               

 

Contacts: LHA Kim Sutton Golodetz kgolodetz@lhai.com 212-838-3777    or Bruce Voss bvoss@lhai.com 310-691-7100

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 89

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
Yoodli's No. 9 Ranking Signals Enterprise AI Traction

Updated Category News Views 96

Ninth place can be easy to dismiss until you notice the company is sitting near the top of a 500-name growth list. Yoodli's No. 9 position on Deloitte's 2026 Technology Fast 500 is a meaningful signal that its AI-based coaching and workforce-skills pitch is getting traction inside large organizations. It is not a revenue disclosure, it is not a valuation marker, and...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 150

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 161

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Frosty Animatronics Put Nostalgia on Lowe's Shelves

Updated Category News Views 114

A moving corncob pipe is not anybody's idea of a macroeconomic signal, yet holiday aisles are built on precisely these little jolts of recognition. Gemmy has teamed with Warner Bros. Discovery Global Consumer Products to place a new animated Frosty the Snowman collection exclusively at Lowe's for the 2026 holiday season. It is cheerful retail business, not earthshaking...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 91

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading
Peñoles Locks In Solar Storage for Northern Mine Loads

Updated Category News Views 45

A mine never sleeps, which is why the battery matters more than the solar-panel headline. Peñoles has signed a 20-year power-supply agreement with Atlas Renewable Energy for a Coahuila project combining 269 MWp of solar generation with battery storage. The project is slated to begin operating in the first half of 2029 and is expected to provide roughly 550 GWh a year to...

Continue Reading
Norfolk Southern's 200-Year Campaign Meets a Hard Market

Updated Category News Views 61

Two centuries of railroad history can stir the blood, but it does not move a single carload by itself. Norfolk Southern has opened its 200-year railroading celebration with the GeneratioNS campaign, a three-locomotive NS 200 commemorative series, and plans for public events across its network. For a railroad with deep roots and very modern operational pressures, this is...

Continue Reading
Watson Motion Tests Military Pretrial Confinement Rules

Updated Category News Views 157

Military confinement fights are rarely neat, and this one comes with a short clock but plenty of unanswered questions. Defense lawyers for U.S. Air Force Maj. Jason Watson argued on Nov. 17 that he should be released from pretrial confinement while his case proceeds. A military judge is ordinarily expected to issue a ruling within 14 days of the hearing, under the court's...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 90

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading

Top 5 Most Recently Viewed Articles

evolv Consulting and Snowflake Join Forces in Automotive Tech

Updated Category News Views 205

evolv Consulting Partners with Snowflake for Automotive Innovation evolv Consulting empowers data-driven insights at scale for the automotive industry through Snowflake AI Data Cloud for Manufacturing. evolv Consulting, recognized as an Elite Snowflake Services partner, has announced a strategic collaboration with Snowflake to enhance the AI Data Cloud for Manufacturing...

Continue Reading
Martela Corporation Shares Decline: Key Updates and Implications

Updated Category News Views 158

Martela Corporation Reports Notable Changes in Shareholding Martela Corporation has recently seen significant transactions that impact its share structure, which is crucial information for investors. On a particular date, Isku-Yhtymä Oy made an important announcement regarding its shareholding in Martela. This report revealed that Isku-Yhtymä Oy had sold enough shares...

Continue Reading
Forecasting Growth in the Chlorine Trifluoride Market by 2032

Updated Category News Views 221

Overview of the Chlorine Trifluoride Market Chlorine trifluoride is emerging as a pivotal player in numerous high-tech applications, with the market anticipated to reach a staggering USD 82.81 million by 2032. This significant growth is fueled by an annual compound growth rate (CAGR) of 4.64% from the previous years. The reactivity of chlorine trifluoride makes it an...

Continue Reading
Ryde Group's Public Offering: Key Insights and Developments

Updated Category News Views 274

Ryde Group Ltd (NYSE American: RYDE) made waves in the market with its public offering valued at approximately $4.5 million. The offering encompassed 5.3 million units, each comprising one Class A Ordinary Share plus a warrant that can be exercised into an additional Ordinary Share at $0.85. With warrants exercisable immediately and valid for five years, traders keen on...

Continue Reading
Citi's Optimistic Forecast for Enel Stock Amid Renewables Growth

Updated Category News Views 145

Citi's Optimistic Outlook on Enel Recently, Citi reaffirmed its strong Buy rating on Enel (BIT: ENEI) SpA stock, maintaining a price target of EUR7.40. This renewed confidence comes ahead of the company's anticipated third-quarter earnings announcement slated for early November. Analysts at Citi predict that Enel is poised to deliver robust financial results, prompting...

Continue Reading